Evidence map›Paper›PMID 42432989›Full record

ArticleScandinavian journal of immunology2026

Impact of Bacterial Membrane Vesicles on Cellular Responses in Leishmania amazonensis-Infected Macrophages In Vitro.

Pedro Henrique Gallo-Francisco, Genesy Pérez Jorge, Guilherme Augusto Sanches Roque, Marina Flóro E Silva, Natália Scanavachia da Silva, Cecília Costa Fagundes, Alexandre Leite Rodrigues Oliveira, Fausto Almeida, Marcelo Brocchi, Selma Giorgio

Abstract read
In one paragraph

Article in Scandinavian journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pedro Henrique Gallo-FranciscoDepartment of Animal Biology, Biology Institute, State University of Campinas, Campinas, Brazil.ORCID https://orcid.org/0000-0001-8419-2051
Genesy Pérez JorgeDepartment of Genetics, Evolution, Microbiology, and Immunology, Biology Institute, State University of Campinas, Campinas, Brazil.ORCID https://orcid.org/0000-0002-2138-7393
Guilherme Augusto Sanches RoqueDepartment of Animal Biology, Biology Institute, State University of Campinas, Campinas, Brazil.
Marina Flóro E SilvaDepartment of Animal Biology, Biology Institute, State University of Campinas, Campinas, Brazil.
Natália Scanavachia da SilvaDepartment of Structural and Functional Biology, Biology Institute, State University of Campinas, Campinas, Brazil.
Cecília Costa FagundesDepartment of Structural and Functional Biology, Biology Institute, State University of Campinas, Campinas, Brazil.
Alexandre Leite Rodrigues OliveiraDepartment of Structural and Functional Biology, Biology Institute, State University of Campinas, Campinas, Brazil.ORCID https://orcid.org/0000-0003-4224-4575
Fausto AlmeidaDepartment of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), São Paulo, Brazil.
Marcelo BrocchiDepartment of Genetics, Evolution, Microbiology, and Immunology, Biology Institute, State University of Campinas, Campinas, Brazil.
Selma GiorgioDepartment of Animal Biology, Biology Institute, State University of Campinas, Campinas, Brazil.ORCID https://orcid.org/0000-0002-5685-9661

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 405581/2018-1Coordination for the Improvement of Superior Level Staff Improvement (CAPES) 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/23302-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/11061-7
6 · The paper itself

Abstract

Leishmania amazonensis is an intracellular protozoan parasite and etiological agent of Localised Cutaneous Leishmaniasis (LCL). A challenge in managing LCL is the frequent occurrence of secondary bacterial co-infections caused by opportunistic bacteria such as Pseudomonas aeruginosa and Staphylococcus aureus. This study aimed to evaluate the effects of Bacterial Membrane Vesicles (BMVs) from these bacteria on macrophages infected with L. amazonensis. BMVs were characterised by Nanoparticle Tracking Analysis (NTA), and their effects on macrophage viability, infection dynamics, and cytokine production were assessed. Macrophages infected with L. amazonensis and subsequently treated with BMVs exhibited reduced parasite burden and cell viability compared to infected controls. The production of cytokines was variably modulated depending on the vesicle source. TNF-α levels were higher in macrophages infected with L. amazonensis and treated with BMVs than in those infected with the parasite alone. Additionally, elevated levels of IL-1β were observed in co-cultures treated with P. aeruginosa membrane vesicles (POMVs), suggesting a stronger inflammatory profile than that induced by S. aureus extracellular vesicles (SEVs). In contrast, IL-4 and IL-6 levels were not significantly affected by either POMVs or SEVs. These results indicate that uninfected and L. amazonensis-infected macrophages respond distinctly to POMVs and SEVs, particularly through enhanced secretion of IL-1β and TNF-α. In conclusion, macrophages exposed to both L. amazonensis and bacterial vesicles simulate a host-parasite-bacteria interaction, activating production of cytokines. Given their immunogenic properties, BMVs may represent promising targets for the development of therapeutic strategies associated with LCL.

Indexed as

Extracellular VesiclesLeishmaniaLeishmania mexicanaLeishmaniasis, CutaneousMacrophagesPseudomonas aeruginosaStaphylococcus aureusAnimalsCell SurvivalCytokinesHumansMiceTumor Necrosis Factor-alphaCytokinesTumor Necrosis Factor-alphabacterial membrane vesiclescytokinesLeishmania amazonensismacrophagesPseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID42432989
PMCPMC13354861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.